XML 16 R5.htm IDEA: XBRL DOCUMENT v3.21.2
UNAUDITED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
shares in Thousands, $ in Thousands
Total
Cumulative Effect Adjustment
Preferred Stock
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Income (Loss)
Retained Earnings
Retained Earnings
Cumulative Effect Adjustment
MYR Group Inc. Stockholders' Equity
MYR Group Inc. Stockholders' Equity
Cumulative Effect Adjustment
Noncontrolling Interest
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Adjustment to adopt ASC 326 $ 364,475 $ (268) $ 0 $ 166 $ 152,532 $ (446) $ 212,219 $ (268) $ 364,471 $ (268) $ 4
Balance, beginning of period at Dec. 31, 2019 364,475 (268) 0 $ 166 152,532 (446) 212,219 (268) 364,471 (268) 4
Balance, beginning of period (in shares) at Dec. 31, 2019       16,649              
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Net income $ 9,932           9,932   9,932    
Accounting Standards Update [Extensible Enumeration] us-gaap:AccountingStandardsUpdate201613Member                    
Stock issued under compensation plans, net $ 82       82       82    
Stock issued under compensation plans, net (in shares)       55              
Stock-based compensation expense 1,080       1,080       1,080    
Shares repurchased (426)       (241)   (185)   (426)    
Shares repurchased (in shares)       (20)              
Other comprehensive income (loss) 87         87     87    
Stock issued - other 24       24       24    
Stock issued - other (in shares)       1              
Balance, end of period at Mar. 31, 2020 374,986   0 $ 166 153,477 (359) 221,698   374,982   4
Balance, end of period (in shares) at Mar. 31, 2020       16,685              
Balance, beginning of period at Dec. 31, 2019 364,475 $ (268) 0 $ 166 152,532 (446) 212,219 $ (268) 364,471 $ (268) 4
Balance, beginning of period (in shares) at Dec. 31, 2019       16,649              
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Net income 23,317                    
Other comprehensive income (loss) 48                    
Balance, end of period at Jun. 30, 2020 389,450   0 $ 167 154,594 (398) 235,083   389,446   4
Balance, end of period (in shares) at Jun. 30, 2020       16,709              
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Adjustment to adopt ASC 326 374,986   0 $ 166 153,477 (359) 221,698   374,982   4
Balance, beginning of period at Mar. 31, 2020 374,986   0 $ 166 153,477 (359) 221,698   374,982   4
Balance, beginning of period (in shares) at Mar. 31, 2020       16,685              
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Net income 13,385           13,385   13,385    
Stock issued under compensation plans, net 1     $ 1         1    
Stock issued under compensation plans, net (in shares)       23              
Stock-based compensation expense 1,093       1,093       1,093    
Other comprehensive income (loss) (39)         (39)     (39)    
Stock issued - other 24       24       24    
Stock issued - other (in shares)       1              
Balance, end of period at Jun. 30, 2020 389,450   0 $ 167 154,594 (398) 235,083   389,446   4
Balance, end of period (in shares) at Jun. 30, 2020       16,709              
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Adjustment to adopt ASC 326 389,450   0 $ 167 154,594 (398) 235,083   389,446   4
Adjustment to adopt ASC 326 429,292   0 167 158,618 23 270,480   429,288   4
Balance, beginning of period at Dec. 31, 2020 429,292   0 $ 167 158,618 23 270,480   429,288   4
Balance, beginning of period (in shares) at Dec. 31, 2020       16,734              
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Net income 19,928           19,928   19,928    
Stock issued under compensation plans, net 110     $ 1 109       110    
Stock issued under compensation plans, net (in shares)       123              
Stock-based compensation expense 1,487       1,487       1,487    
Shares repurchased (2,618)       (2,231)   (387)   (2,618)    
Shares repurchased (in shares)       (41)              
Other comprehensive income (loss) 253         253     253    
Stock issued - other 12       12       12    
Stock issued - other (in shares)       1              
Balance, end of period at Mar. 31, 2021 448,464   0 $ 168 157,995 276 290,021   448,460   4
Balance, end of period (in shares) at Mar. 31, 2021       16,817              
Balance, beginning of period at Dec. 31, 2020 429,292   0 $ 167 158,618 23 270,480   429,288   4
Balance, beginning of period (in shares) at Dec. 31, 2020       16,734              
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Net income 41,147                    
Other comprehensive income (loss) 666                    
Balance, end of period at Jun. 30, 2021 471,629   0 $ 168 159,624 689 311,144   471,625   4
Balance, end of period (in shares) at Jun. 30, 2021       16,867              
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Adjustment to adopt ASC 326 448,464   0 $ 168 157,995 276 290,021   448,460   4
Balance, beginning of period at Mar. 31, 2021 448,464   0 $ 168 157,995 276 290,021   448,460   4
Balance, beginning of period (in shares) at Mar. 31, 2021       16,817              
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Net income 21,219           21,219   21,219    
Stock issued under compensation plans, net 319     $ 1 318       319    
Stock issued under compensation plans, net (in shares)       60              
Stock-based compensation expense 1,948       1,948       1,948    
Shares repurchased (734)     $ (1) (637)   (96)   (734)    
Shares repurchased (in shares)       (10)              
Other comprehensive income (loss) 413         413     413    
Balance, end of period at Jun. 30, 2021 471,629   0 $ 168 159,624 689 311,144   471,625   4
Balance, end of period (in shares) at Jun. 30, 2021       16,867              
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Adjustment to adopt ASC 326 $ 471,629   $ 0 $ 168 $ 159,624 $ 689 $ 311,144   $ 471,625   $ 4